Last Updated 24 January 2022.
9 Vaccines Approved for Use in Argentina
-
Moderna
Spikevax- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 85 countries
45 trials in 19 countries
Approval Source: saludneuquen.gob.ar
-
Pfizer/BioNTech
Comirnaty- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 136 countries
58 trials in 24 countries
Approval Source: riotimesonline.com
-
CanSino
Convidecia- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 10 countries
13 trials in 6 countries
Approval Source: apnews.com
-
Gamaleya
Sputnik Light- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 24 countries
4 trials in 2 countries
Approval Source: tass.com
-
Gamaleya
Sputnik V- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 74 countries
22 trials in 7 countries
Approval Source: reuters.com
-
Oxford/AstraZeneca
Vaxzevria- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 137 countries
56 trials in 30 countries
Approval Source: reuters.com
-
Serum Institute of India
Covishield (Oxford/AstraZeneca formulation)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 47 countries
2 trials in 1 country
Approval Source: batimes.com.ar
-
Sinopharm (Beijing)
Covilo- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 88 countries
22 trials in 11 countries
Approval Source: xinhuanet.com
-
Sinovac
CoronaVac- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 52 countries
29 trials in 9 countries
Approval Source: xinhuanet.com
10 Vaccines in Clinical Trials in Argentina
-
Medicago
Plant-based VLP- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
6 trials in 6 countries
-
Moderna
Spikevax- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 85 countries
45 trials in 19 countries
-
Pfizer/BioNTech
Comirnaty- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 136 countries
58 trials in 24 countries
-
CanSino
Convidecia- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 10 countries
13 trials in 6 countries
-
Gamaleya
Sputnik Light- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 24 countries
4 trials in 2 countries
-
Gamaleya
Sputnik V- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 74 countries
22 trials in 7 countries
-
Janssen (Johnson & Johnson)
Ad26.COV2.S- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 106 countries
18 trials in 18 countries
-
Oxford/AstraZeneca
Vaxzevria- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 137 countries
56 trials in 30 countries
-
ReiThera
GRAd-COV2- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
5 trials in 12 countries
-
Sinopharm (Beijing)
Covilo- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 88 countries
22 trials in 11 countries
1 Vaccines with Trials in Argentina are No Longer Progressing
-
Curevac
CVnCoV- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
9 trials in 12 countries